The Liquid Biopsy Summit is dedicated to primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cel.
Topics
Clinical integration of liquid biopsy
Liquid Biopsy: New Opportunities, Technologies, and Challenges in the Field
Improving the Quality of Circulating Tumor DNA Measurements
Circulating Tumor Cells: History and Future Perspectives
Extracellular vesicles (Evs)
Circulating Tumor Cells in Monitoring Cancer
CTC Isolation Platforms and Using CTCs for Monitoring Therapy Responses
New Tools for Liquid Biopsies: Microfluidic Platforms for the Isolation of CTCs, cfDNA and Exosomes
Liquid Biopsies in Cancer Immunotherapy Clinical Drug Development
Dissecting Mechanisms of Breast Cancer Metastasis Using Patient Derived Circulating Tumor Cells
Liquid Biopsies in Oncology and the Current Regulatory Landscape
Heterogeneity of Cancer-Derived Extracellular Vesicles
CtDNA Liquid Biopsy Assay
Validating Liquid Biopsies in Cancer
Past Events
Liquid Biopsy Summit - 20-21 Feb 2020, Myriad by Sana Hotel, Lisbon, Portugal (87961)
Important
Please, check "Liquid Biopsy Summit" official website for possible changes, before making any traveling arrangements